Back to Results
First PageMeta Content
Epidemiology / Drug discovery / Clinical research / Pharmacology / Pharmaceutical industry / Orphan drug / Rare disease / Genetic Alliance UK / National Institute for Health and Clinical Excellence / Health / Pharmaceutical sciences / Medicine


Consultation Response Innovation Pass Pilot Department of Health Response by the Genetic Interest Group and Rare Disease UK The Genetic Interest Group (GIG) is the UK national alliance for all people affected by genetic
Add to Reading List

Document Date: 2010-02-15 07:54:39


Open Document

File Size: 306,28 KB

Share Result on Facebook

Company

The Genetic Interest Group / Rare Disease UK Genetic Interest Group / Rare Disease UK / /

Continent

Europe / /

Country

United States / United Kingdom / Scotland / Wales / /

/

IndustryTerm

conventional health technology assessment rules / therapy for Gaucher’s Disease / pharmaceutical industry / therapies for rare diseases / health technology assessment processes / orphan medicinal products / /

MedicalCondition

rare diseases / rare and genetic disorders / Gaucher’s Disease / inborn errors of metabolism / very rare diseases / /

MedicalTreatment

enzyme replacement therapy / innovative therapies / /

Organization

Scientific Advice Working Party / Dept of Health / European Medicines Agency / Committee for Medicinal Products for Human / office of Life Science / UK national alliance / office of Life Sciences Blueprint / Department of Health / NHS / NICE / /

Person

Alastair Kent / /

Position

Director / Chair / pilot scheme / /

Technology

tissue engineering / stem cells / /

URL

www.raredisease.org.uk / www.gig.org.uk / /

SocialTag